The aim of the study was to evaluate the nutritional status of patients suffering from head and neck cancer at the beginning of the specific treatment, through the use of biochemical parameters (1) . Body weight (w, kg) and height (h, m) were determined, and the BMI calculated in 20 adults, who attended TRU, Angel Roffo Institute of Oncology. Blood samples were collected from fasting patients. Specific serum protein fractions of potential usefulness in nutrition studies: transthyretin (TTR), transferrin (Transf), C3 (C3c) and C4 complement (C4c); and acute phase serum fractions: ceruloplasmin (Cp), haptoglobin (Hapto) and protein C reactive (PCR) were measured by single radial immunodiffusion technique on agar gel layers (Biocientífica S.A., Argentina and Binding Site, UK) (2,3) . Clinical aspects were evaluated by Bioelectrical Impedance Analysis (BIA that determines electrical properties of the body resistance (R) and capacitance (Xc)); and basal metabolism (BM). We calculated the phase angle (arc tangent of the ratio Xc to R in degrees) that measures lean body mass (3) . Biochemical parameters (mg/dl), and BMI (kg/m 2 ) expressed as means and SD, were compared with reference values (VR). The data showed lower TTR, C3c and Transferrin together with higher Cp and Haptoglobin sera levels, than reference values. Results pointed out to a depressed nutritional status and inflammation. Besides, only 10 % showed BMI < 18.5 %. Thirty-five percent patients had reduction of phase angle and 15 % had increased of BM with increased PCR. These findings stress the importance of the inclusion of functional biochemical parameters in the periodic nutritional evaluation of these patients. This would allow an early assessment of the need for appropriate nutritional support, since 70 % of patients had normal BM and in this situation patients re-feeding is possible (1,4) ; on the other hand, patients with increased BM and phase angle (30-25 % respectively) could be a subgroup with systemic inflammatory status where re-feeding may not be useful.
Nutritional status depression in persons suffering from head and neck cancer has been scarcely study. An inadequate nutrient intake could be the principal factor (1)(2)(3) . Previous study in a group of patients underwent conventional therapy showed changes in specific serum protein fractions, indicative of an impairment of nutritional status and inflammation (4) . The goal is the evaluation of nutritional status through the use of biochemical parameters in a subgroup of adult patients suffering from head and neck cancer before and after oral intake of a nutritional supplement.The study was performed on seven patients (n = 7, 45-60 years old), who were attended in the Angel Roffo Institute, with local advanced head and neck cancer, underwent therapy with Chemoradiotherapy that completed oral intake of a nutritional supplement, during 60 days (Supportan 1 , Fresenius-Kabi ). The supplement provides 500 Kcal/day, with 27 % of total calories cover by proteins, 40 % by lipids (2 g EPA provided by fish oil, MCT and vegetal oils) and 33 % of carbohydrates. Patients had not severe mucositis -ulcera, bleeding and/or infection. Never of them had another severe toxicity by treatment nor had impairment of Perfomance Status. Blood samples were collected from fasting patients before (To) and after (Tf) the oral administration of the supplement. Specific serum protein fractions of potential usefulness in nutrition studies: transthyretin (TTR), transferrin (Transf), C3 (C3c), and C4 (C4c); acute phase serum fractions: ceruloplasmin (Cp), haptoglobin (Hp) and protein C reactive (PCR) were measured by single radial immunodiffusion technique on agar gel layers (Biocientífica S.A., Argentina and Binding Site, UK). Biochemical parameters (Tf vs To) (mg/dl),expressed as X (SD) were: TTR: 21.1 (8.9) vs 22.9 (7.3); Transf: 188.9 (36.1) vs 207.3 (20.9); C3c:122.6 (24.9) vs 122.5 (52.3); C4c: 37.5 (7.4) vs 38.9 (11.1); Cp: 40.0 (6.7) vs 36.1(11.7), Hp: 334.0 (194.2) vs 245.6 (103.9); PCR: 1.4 (0.3) vs 1.6 (2.1). No differences between Tf and To were observed. These preliminary results suggest that the oral supplement administration was useful to maintain the initial biochemical nutritional profile. As a matter of fact, we consider a probable beneficial tendency in the implementation of this oral supplement to this type of treatment for head and neck carcinoma.
A balanced and varied diet is important to maintain optimal health status and prevent diseases. Dietary fatty acid profile has an essential function as an immune system regulator. Thymus is a biological marker of nutritional disorders (1) . The aim of this study was to analyze the effect of diets containing high fat levels from different dietary sources on thymus weight, total number of thymocytes, and fatty acid composition of the thymus in adult rats.Wistar rats (n = 18; 50 days of age) were divided into three groups and fed during 40 days with diets containing 1) 50 kcal % fat provided by butter (group B), 2) 50 kcal % fat provided by sunflower oil (group S) and 3) normocaloric diet provided by soy oil (group C). All diets had 20 % protein (casein) and were complete in all other nutrients according to AIŃ 93. Dietary fatty acid profile was determined by gas chromatography (GC) and w6/w3 and unsaturated/saturated (U/S) ratios were calculated. At the end of the feeding period, animals were sacrificed and thymus was removed. Thymus weights (TW), total number of thymocytes (NC) and fatty acid profile of thymus were determined. ANOVA test was performed. Results expressed as mean(SD): w6/w3 diet ratio: B: 8.7/1, S: 250/1, C: 9/1; U/S diet ratio: B: 0.54, S: 9.2, C: 5.0; TW (mg): B:511.6(74.5), S:548.2(70.4), C:570.8(52.0); NC (cells · 10 -7
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.